Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation NY Valves 2024

Lessons From the Initial FDA Trials

Presenter: David J. Cohen

June 06, 2024

Presentation Fellows 2023

Top 10 Interventional Cardiology Trials You Need to Know (and Why)

Presenter: David Cohen

May 11, 2023

Presentation TCT 2022

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Presenter: David J. Cohen

September 17, 2022

Presentation TCT 2019

Balancing Efficacy and Safety in Trial Interpretation

Presenter: David Cohen

September 27, 2019

Presentation Fellows 2019

Essentials of Clinical Trial Design

Presenter: David J. Cohen

April 12, 2019

Presentation TCT 2018

Pathways for Same-Day PCI Discharge

Presenter: David A. Cox, Dmitriy N. Feldman, Mauricio G. Cohen

September 24, 2018

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation Fellows 2016

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

Presenter: Gary S. Mintz, David J. Cohen

April 16, 2016

Presentation Fellows 2015

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

Presenter: Gary S. Mintz, Ajay J. Kirtane, David J. Cohen

May 16, 2015

Presentation TCT 2014

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Jae-Sik Jang, MD

September 13, 2014

Presentation TCT 2014

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Daniele Giacoppo, MD

September 13, 2014

Presentation TCT 2014

Meta-analysis: From PRISMA Standards to Utility in Guiding Practice

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Definition, Reliability, and Interpretation of Surrogate Endpoints

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen

September 13, 2014

Presentation TCT 2014

Subgroup Analyses: Proceed (and Interpret) with Caution

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Eugene H. Blackstone

September 13, 2014

Presentation TCT 2014

Randomized vs Observational Studies: Strengths and Weaknesses

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen

September 13, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

Presentation Fellows 2014

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

Presenter: David Cohen

April 12, 2014

Presentation TCT 2012

A Stepwise Approach to Building a Career in Interventional Cardiology Research

Presenter: David Cohen

October 25, 2012

Presentation TCT 2012

An Introduction to Cost-Effectiveness Analyses: Who Pays (and Should They)?

Presenter: David Cohen

October 22, 2012

Presentation Fellows 2012

Essentials of Clinical Trial Design

Presenter: David Cohen

April 20, 2012

Advertisement

Lessons From the Initial FDA Trials

Top 10 Interventional Cardiology Trials You Need to Know (and Why)

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Balancing Efficacy and Safety in Trial Interpretation

Essentials of Clinical Trial Design

Pathways for Same-Day PCI Discharge

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

TCT 252: Preprocedural Statin Administration Benefit According to Baseline Renal Function: A Meta-analysis of Randomized Controlled Trials

Meta-analysis: From PRISMA Standards to Utility in Guiding Practice

Definition, Reliability, and Interpretation of Surrogate Endpoints

Subgroup Analyses: Proceed (and Interpret) with Caution

Randomized vs Observational Studies: Strengths and Weaknesses

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

A Stepwise Approach to Building a Career in Interventional Cardiology Research

An Introduction to Cost-Effectiveness Analyses: Who Pays (and Should They)?

Essentials of Clinical Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content